Organon & Co
F:7XP
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
O
|
Organon & Co
F:7XP
|
US |
|
K
|
Kforce Inc
XMUN:ROF
|
US |
|
Outlook Therapeutics Inc
F:41O
|
US |
|
S
|
Salesforce Inc
F:FOO
|
US |
|
I
|
IWG Plc
F:IWG
|
CH |
|
R
|
Revance Therapeutics Inc
F:RTI
|
US |
|
I
|
Indo Tambangraya Megah Tbk PT
XMUN:3IB
|
ID |
|
Z
|
Zions Bancorporation NA
F:ZB1
|
US |
|
T
|
Telenor ASA
DUS:TEQ
|
NO |
|
Global Industrial Co
F:GML0
|
US |
|
Electro-Sensors Inc
NASDAQ:ELSE
|
US |
|
V
|
Vesuvius PLC
F:V4S
|
UK |
|
Z
|
Ziff Davis Inc
XMUN:JXC1
|
US |
|
Akari Therapeutics PLC
F:CLA
|
US |
|
S
|
Saul Centers Inc
F:SA4
|
US |
Wall St Price Targets
7XP Price Targets Summary
Organon & Co
According to Wall Street analysts, the average 1-year price target for 7XP is 6.38 EUR with a low forecast of 4.68 EUR and a high forecast of 8.51 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is 7XP's stock price target?
Price Target
6.38
EUR
According to Wall Street analysts, the average 1-year price target for 7XP is 6.38 EUR with a low forecast of 4.68 EUR and a high forecast of 8.51 EUR.
What is the Revenue forecast for Organon & Co?
Projected CAGR
0%
Over the last 7 years, the compound annual growth rate for Revenue has been -6%. The projected CAGR for the next 7 years is 0%.
What is the Operating Income forecast for Organon & Co?
Projected CAGR
4%
Over the last 7 years, the compound annual growth rate for Operating Income has been -10%. The projected CAGR for the next 7 years is 4%.
What is the Net Income forecast for Organon & Co?
Projected CAGR
26%
Over the last 7 years, the compound annual growth rate for Net Income has been -29%. The projected CAGR for the next 7 years is 26%.
